Cargando…
The long road to TRAIL therapy: a TRAILshort detour
Autores principales: | Chandrasekar, Aswath P., Maynes, Mark, Badley, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021024/ https://www.ncbi.nlm.nih.gov/pubmed/33868580 http://dx.doi.org/10.18632/oncotarget.27902 |
Ejemplares similares
-
The VASP Road to NAFLD: A Macrophage Detour
por: Lastra, Guido, et al.
Publicado: (2015) -
Prime, shock and kill: BCL-2 inhibition for HIV cure
por: Chandrasekar, Aswath P., et al.
Publicado: (2022) -
CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
por: Long, Kristen B., et al.
Publicado: (2018) -
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model
por: Chandrasekar, Aswath P., et al.
Publicado: (2022) -
Lead detour
por: van den Broek, L. M., et al.
Publicado: (2019)